Unexplained weight loss (UWL), defined as a loss of more than 5% of body weight within a six-to-twelve-month period, is a clinical challenge that often signals serious underlying pathology. A comprehensive, systematic approach is crucial in diagnosing the cause of UWL in patients.
The initial evaluation should include a detailed history and physical examination. Key elements to consider are the timeframe of weight loss, associated symptoms, medication history, psychosocial factors, and family history. Physical examination should focus on signs of malnutrition, malignancy, endocrine disorders, and chronic diseases.
Initial laboratory investigations should include complete blood count, comprehensive metabolic panel, thyroid function tests, HIV test, and urinalysis. The decision to proceed with further diagnostic imaging should be guided by the clinical suspicion raised from the history and physical examination.
If initial investigations are inconclusive, more specialized testing may be warranted. This could include endoscopic procedures, cardiac evaluation, or psychiatric assessment, depending on the suspected underlying cause.
Management should be tailored to the identified cause. If no cause is found after a comprehensive evaluation, the patient should be closely monitored with scheduled follow-ups. In some cases, UWL may be the first sign of a disease that will become clinically evident with time.
Unexplained weight loss is a complex clinical issue that requires a comprehensive and systematic approach for effective diagnosis. By thoroughly evaluating the patient's history, physical examination, and appropriate laboratory and imaging studies, healthcare professionals can identify potential causes and initiate appropriate management strategies. Continued vigilance in follow-up is crucial as UWL may be an early indication of a yet-to-be-diagnosed condition.
1.
For MDS-Related Anemia, Telomerase Inhibitor Approved.
2.
Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma
3.
Admissions, medical schools, costs, and eligibility requirements information for FNB Onco-Anesthesia.
4.
Treating Depression: Crucial for Recovery From Fibromyalgia
5.
In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.
1.
Empowering Oncology with Data: Cloud Security, Real-World Evidence, and Clinical Insights
2.
Immune Regulation of Blood Cell Development
3.
Exploring the Effects of Radiation Therapy on Cystitis: A Journey to Better Health
4.
Transformative Frameworks in Oncology for Better Care
5.
Liposomal Doxorubicin and Mitomycin in Modern Cancer Treatment
1.
International Conference on Oncology, Cancer Prevention and Public Health
2.
International Conference on Cancer Nursing and Rehabilitation Strategies
3.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
4.
International Conference on Innovations in Critical Care for Oncology and Cardiology
5.
International Symposium on Oncology, Cardiology and Critical Care Innovations
1.
Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment
2.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
3.
Understanding the causes of anemia in adults beyond nutritional deficiencies
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III
5.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation